ArticleScience China. Life sciences2026

Structure-based classification for differential tyrosine kinase inhibitors efficacy of EGFR exon 19 deletions in non-small cell lung cancer.

Wei Zhuang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.